164 related articles for article (PubMed ID: 2993387)
1. Inhibition of cyclic AMP-dependent protein kinase-induced changes in the kinetic properties of hepatic pyruvate kinase by the specific cyclic AMP antagonist, the (Rp)-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Rothermel JD; Houlihan MJ; Botelho LH
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):371-82. PubMed ID: 2993387
[TBL] [Abstract][Full Text] [Related]
2. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate.
Connelly PA; Botelho LH; Sisk RB; Garrison JC
J Biol Chem; 1987 Mar; 262(9):4324-32. PubMed ID: 3031072
[TBL] [Abstract][Full Text] [Related]
3. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic 3',5'-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase.
Rothermel JD; Perillo NL; Marks JS; Botelho LH
J Biol Chem; 1984 Dec; 259(24):15294-300. PubMed ID: 6096366
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Olivieri MC; Botelho LH
Biochem J; 1986 Jul; 237(2):463-8. PubMed ID: 3026318
[TBL] [Abstract][Full Text] [Related]
5. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
[TBL] [Abstract][Full Text] [Related]
6. Isoproterenol inhibits rod outer segment phagocytosis by both cAMP-dependent and independent pathways.
Kuriyama S; Hall MO; Abrams TA; Mittag TW
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):730-6. PubMed ID: 7890503
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Rothermel JD; Stec WJ; Baraniak J; Jastorff B; Botelho LH
J Biol Chem; 1983 Oct; 258(20):12125-8. PubMed ID: 6313639
[TBL] [Abstract][Full Text] [Related]
8. Effects of (Sp)- and (Rp)-adenosine cyclic 3',5'-phosphorothioates on electrolyte excretion by the isolated perfused rat kidney.
Scheinman SJ; Stec WJ; Coulson R
Miner Electrolyte Metab; 1985; 11(2):85-90. PubMed ID: 2985944
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Rothermel JD; Jastorff B; Botelho LH
J Biol Chem; 1984 Jul; 259(13):8151-5. PubMed ID: 6330102
[TBL] [Abstract][Full Text] [Related]
11. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro.
Ljunggren O; Ljunghall S
Biochem Biophys Res Commun; 1993 Jun; 193(3):821-6. PubMed ID: 8391806
[TBL] [Abstract][Full Text] [Related]
12. Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3'-5'-monophosphate, and insulin in the perfused rat liver.
Blair JB; Cimbala MA; Foster JL; Morgan RA
J Biol Chem; 1976 Jun; 251(12):3756-62. PubMed ID: 180008
[TBL] [Abstract][Full Text] [Related]
13. Regulation by glucagon of hepatic pyruvate kinase, 6-phosphofructo 1-kinase, and fructose-1,6-bisphosphatase.
Pilkis SJ; El-Maghrabi MR; McGrane M; Pilkis J; Claus TH
Fed Proc; 1982 Aug; 41(10):2623-8. PubMed ID: 6286362
[TBL] [Abstract][Full Text] [Related]
14. Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells.
Yokozaki H; Tortora G; Pepe S; Maronde E; Genieser HG; Jastorff B; Cho-Chung YS
Cancer Res; 1992 May; 52(9):2504-8. PubMed ID: 1314695
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase.
Rothermel JD; Parker Botelho LH
Biochem J; 1988 May; 251(3):757-62. PubMed ID: 2843164
[TBL] [Abstract][Full Text] [Related]
16. Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I.
Dostmann WR; Taylor SS
Biochemistry; 1991 Sep; 30(35):8710-6. PubMed ID: 1653606
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3',5'-monophosphorothioate.
Erneux C; Van Sande J; Jastorff B; Dumont JE
Biochem J; 1986 Feb; 234(1):193-7. PubMed ID: 3010952
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions.
Koh MT; Thiele TE; Bernstein IL
Behav Neurosci; 2002 Dec; 116(6):1070-4. PubMed ID: 12492305
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase and protein kinase C contribute to the inhibition by interleukin 6 of phosphoenolpyruvate carboxykinase gene expression in cultured rat hepatocytes.
Christ B; Yazici E; Nath A
Hepatology; 2000 Feb; 31(2):461-8. PubMed ID: 10655271
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of glucagon-induced effects on hepatic glucose metabolism in the presence of insulin and a cAMP antagonist.
Marks JS; Botelho LH
J Biol Chem; 1986 Dec; 261(34):15895-9. PubMed ID: 3023331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
